The Latest Breaking News from Cigna

The hospital estimated the biopsy would cost $1,400. How did it end up being so much more, even with insurance?

What's better than a big fat S&P 500 dividend? One that's rising fast. And there's a surprising number of S&P 500 stocks doing it.

The Nasdaq extended its losing streak Tuesday, with the Apple iPhone 14 on tap. Enphase Energy leads 5 relative winners.

Persistent economic turbulence and an uncertain outlook have led investors to prioritize steady income generation from their investments. Hence, fundamentally sound dividend yielders with a solid track record and potential for perpetual growth Merck (MRK), Abbott (ABT), Cigna (CI), Energy Transfer (ET), and Kronos (KRO) could be permanent additions to…

A whale with a lot of money to spend has taken a noticeably bearish stance on Cigna. Looking at options history for Cigna (NYSE:CI) we detected 15 strange trades.

When Dani Yuengling felt a lump in her right breast last summer, she tried to ignore it.

A hospital's cost calculator said her procedure would be $1,400 for patients without insurance. Instead, the bill was almost $18,000 and, her part was more than $5,000 — the balance of her deductible.

Someone with a lot of money to spend has taken a bearish stance on Cigna (NYSE:CI). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Humana earnings flew past estimates, following Centene's Q2 beat. Centene's outlook may be even brighter if there's a recession.

A whale with a lot of money to spend has taken a noticeably bearish stance on Cigna. Looking at options history for Cigna (NYSE:CI) we detected 13 strange trades.

Several IBD 50 stocks that have recently broken out of bases are struggling to advance amid a sluggish overall market.